ZooMAb antibodies represent an entirely new generation of recombinant monoclonal antibodies.Each ZooMAb antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb antibodies are reliably available and ready to ship when you need them.
Storage: 2-8C
Application: Quality Control TestingEvaluated by Western Blotting in U251 cell lysate.Western Blotting Analysis: A 1:1,000 dilution of this antibody detected BSN in U251 cell lysate.Tested ApplicationsWestern Blotting Analysis: A 1:1,000 dilution from a representative lot detected BSN in PC12 cell lysate.Affinity Binding Assay: A representative lot of this antibody bound BSN peptide with a KD of 1.6 x 10-7 in an affinity binding assay.Immunohistochemistry (Paraffin) Analysis: A 1:100 dilution from a representative lot detected BSN in human cerebral cortex and human retina tissue sections.Immunocytochemistry Analysis: A 1:100 dilution from a representative lot detected BSN in E18 Rat hippocampal neurons.Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user
Legal Information: ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany